$46.44 0.27 (+0.58%)
2/13/2012 10:43 AM

Covance, Inc. (NYSE:CVD)

CAPS Rating: 3 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Featured Broker Partners


Advertisement